News & Analysis as of

Small and Medium-Sized Enterprises (SMEs) Patents

Kidon IP

Response to the USPTO, The ITA, and NIST call for Public Comments on Standards, Part 6 of 7

Kidon IP on

On November 6, 2023 I submitted a response to the public comments which can be found here. I have also included my comments in full on this blog in a series of posts including the below. The only change in my submission is...more

Kidon IP

Response to the USPTO, The ITA, and NIST call for Public Comments on Standards, Part 5 of 7

Kidon IP on

On November 6, 2023 I submitted a response to the public comments which can be found here. I have also included my comments in full on this blog in a series of posts including the below. The only change in my submission is...more

Kidon IP

Response to the USPTO, The ITA, and NIST call for Public Comments on Standards, Part 3 of 7

Kidon IP on

On November 6, 2023 I submitted a response to the public comments which can be found here.  I have also included my comments in full on this blog in a series of posts including the below.  The only change in my submission is...more

Kidon IP

Response to the USPTO, The ITA, and NIST call for Public Comments on Standards, Part 2 of 7

Kidon IP on

On November 6, 2023 I submitted a response to the public comments which can be found here.  I have also included my comments in full on this blog in a series of posts including the below.  The only change in my submission is...more

Hogan Lovells

Three reasons why you should not overlook the Unitary Patent

Hogan Lovells on

This latest publication in our UPC series takes you through three main advantages of the Unitary Patent system, compared to previous protection options: costs and simplicity, centralized proceedings, and benefits for future...more

Morgan Lewis

Taking Advantage of the New Purple Book Patent Requirements for Biologics

Morgan Lewis on

New federal legislation will take effect this year that will require a reference product sponsor to submit to the FDA a list of any patents identified to a biosimilar applicant during the patent dance. The FDA is required to...more

Bennett Jones LLP

Government Funding Opportunities for SMEs

Bennett Jones LLP on

The lack of readily available funds that often exists within a growing small or medium technology enterprise (Tech-SME) can result in management having to juggle many competing priorities; unfortunately, this sometimes means...more

Smart & Biggar

New Program for Québec companies rewards innovation with financial assistance

Smart & Biggar on

Recently the province of Quebec’s Ministère de l’Économie et de l’Innovation launched a new Innovation Program (Programme Innovation) to provide Quebec-based companies and companies having a place of business in Quebec with...more

Hogan Lovells

UK Intellectual Property Office (IPO) responds to Industrial Strategy Consultation

Hogan Lovells on

In November 2017 the UK government published its Industrial Strategy. As part of this, the UK IPO made a broad ‘call for views’ from users of the UK intellectual property system on “products, services or other activities the...more

Carlton Fields

Expect Focus – International, Summer 2015

Carlton Fields on

In This Issue: - TTIP’s Impact on U.S. and EU Trade Relations - Proposed Innovation Box Legislation - Justice Department Recovers Nearly $6 Billion From False Claims Act Cases in 2014 - Rules...more

10 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide